Urinary tract infections (UTIs) are the second most widespread problem of pregnancy next to anemia, which can be asymptomatic or symptomatic. UTIs usually starts at week six of pregnancy and peaks between weeks 22 and 24.This could be due to hormonal changes, glycosuria (increased sugar in the urine promoting bacterial growth), short urethra, hygiene difficulties due to a distended pregnant belly, increasing gestational age, parity, maternal age, frequency of sexual intercourse, comorbidities like diabetes and sickle cell disease, previous UTI history, previous catheterization, immunosuppression, tobacco use, late presentation for prenatal care, and previous use of third-generation cephalosporins. Escherichia coli the most common and dominant micro-organism is accountable for over 90% UTIs during pregnancy. In addition Proteus mirabilis, Klebsiella pneumoniae, Enterobacter species; Staphylococcus sciuri, Staphylococcus lentus, Staphylococcus vitulinus, Staphylococcus pulvereri, Staphylococcus xylosus, and Group B beta-hemolytic streptococcus reported causes UTIs during pregnancy even though their occurrence is rare. The presence of biofilms can pose challenges for the immune system and antibiotic treatment. Because biofilm-associated illnesses can withstand a typical five to ten days of antibiotic therapy, multi-targeted or combination antibiotic regimens are required. Therefore, it is important to routinely investigate the prevalence of UTIs with antibacterial resistance among pregnant women and design appropriate interventions that tackle the Feto-maternal complications.
This Research Topic Aimed To Determine Prevalence of Urinary Tract Infection, Antimicrobial Resistance and Molecular Epidemiology of Uropathogenic Escherichia coli among Pregnant Women through collection of themes of articles to be published, with target of recommending appropriate tangible interventions that tackles, the prevalence of UTIs, Antimicrobial resistance, and more Specifically molecular epidemiology of Uropathogenic Escherichia coli among pregnant women.
The Research Topic would like to Address Prevalence of UTIs, Causal Agents, Antimcrobial Resistance, and Molecular Epidemiology of UPEC, among pregnant women from all of the world. Therefore, The contributors would contribute of the above listed themes of the topic.
Keywords:
UTIs, Uropathogen, Escherichia coli, Pregnant women, Antimicrobial resistance
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Urinary tract infections (UTIs) are the second most widespread problem of pregnancy next to anemia, which can be asymptomatic or symptomatic. UTIs usually starts at week six of pregnancy and peaks between weeks 22 and 24.This could be due to hormonal changes, glycosuria (increased sugar in the urine promoting bacterial growth), short urethra, hygiene difficulties due to a distended pregnant belly, increasing gestational age, parity, maternal age, frequency of sexual intercourse, comorbidities like diabetes and sickle cell disease, previous UTI history, previous catheterization, immunosuppression, tobacco use, late presentation for prenatal care, and previous use of third-generation cephalosporins. Escherichia coli the most common and dominant micro-organism is accountable for over 90% UTIs during pregnancy. In addition Proteus mirabilis, Klebsiella pneumoniae, Enterobacter species; Staphylococcus sciuri, Staphylococcus lentus, Staphylococcus vitulinus, Staphylococcus pulvereri, Staphylococcus xylosus, and Group B beta-hemolytic streptococcus reported causes UTIs during pregnancy even though their occurrence is rare. The presence of biofilms can pose challenges for the immune system and antibiotic treatment. Because biofilm-associated illnesses can withstand a typical five to ten days of antibiotic therapy, multi-targeted or combination antibiotic regimens are required. Therefore, it is important to routinely investigate the prevalence of UTIs with antibacterial resistance among pregnant women and design appropriate interventions that tackle the Feto-maternal complications.
This Research Topic Aimed To Determine Prevalence of Urinary Tract Infection, Antimicrobial Resistance and Molecular Epidemiology of Uropathogenic Escherichia coli among Pregnant Women through collection of themes of articles to be published, with target of recommending appropriate tangible interventions that tackles, the prevalence of UTIs, Antimicrobial resistance, and more Specifically molecular epidemiology of Uropathogenic Escherichia coli among pregnant women.
The Research Topic would like to Address Prevalence of UTIs, Causal Agents, Antimcrobial Resistance, and Molecular Epidemiology of UPEC, among pregnant women from all of the world. Therefore, The contributors would contribute of the above listed themes of the topic.
Keywords:
UTIs, Uropathogen, Escherichia coli, Pregnant women, Antimicrobial resistance
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.